Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
43.75
+0.83 (1.93%)
Apr 24, 2025, 2:45 PM CST
SHE:002653 Revenue
In the year 2024, Haisco Pharmaceutical Group had annual revenue of 3.72B CNY with 10.92% growth. Haisco Pharmaceutical Group had revenue of 970.11M in the quarter ending December 31, 2024, a decrease of -0.11%.
Revenue
3.72B
Revenue Growth
+10.92%
P/S Ratio
13.04
Revenue / Employee
697.27K
Employees
5,337
Market Cap
48.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.72B | 366.28M | 10.92% |
Dec 31, 2023 | 3.36B | 339.78M | 11.27% |
Jan 1, 2023 | 3.02B | 241.98M | 8.73% |
Jan 1, 2022 | 2.77B | -556.28M | -16.71% |
Dec 31, 2020 | 3.33B | -607.74M | -15.44% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.77B |
Aier Eye Hospital Group | 20.62B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |